139 related articles for article (PubMed ID: 28761575)
1. Chemical Stability of Ceftolozane/Tazobactam in Polyvinylchloride Bags and Elastomeric Pumps.
Terracciano J; Rhee EG; Walsh J
Curr Ther Res Clin Exp; 2017; 84():22-25. PubMed ID: 28761575
[TBL] [Abstract][Full Text] [Related]
2. Ceftolozane-tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study.
Raby E; Naicker S; Sime FB; Manning L; Wallis SC; Pandey S; Roberts JA
Eur J Hosp Pharm; 2020 Mar; 27(e1):e84-e86. PubMed ID: 32296512
[TBL] [Abstract][Full Text] [Related]
3. Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers.
Hossain MA; Friciu M; Aubin S; Leclair G
Am J Health Syst Pharm; 2014 Apr; 71(8):669-73. PubMed ID: 24688042
[TBL] [Abstract][Full Text] [Related]
4. Chemical Stability of Telavancin in Elastomeric Pumps.
Sand P; Aladeen T; Kirkegaard P; LaChance D; Slover C
Curr Ther Res Clin Exp; 2015 Dec; 77():99-104. PubMed ID: 26649079
[TBL] [Abstract][Full Text] [Related]
5. Stability of doripenem in polyvinyl chloride bags and elastomeric pumps.
Crandon JL; Sutherland C; Nicolau DP
Am J Health Syst Pharm; 2010 Sep; 67(18):1539-44. PubMed ID: 20811032
[TBL] [Abstract][Full Text] [Related]
6. Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device.
Smith DL; Bauer SM; Nicolau DP
Am J Health Syst Pharm; 2004 Aug; 61(16):1682-5. PubMed ID: 15540479
[TBL] [Abstract][Full Text] [Related]
7. Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags.
Gu Z; Wong A; Raquinio E; Nguyen A
Hosp Pharm; 2015 Jul; 50(7):609-14. PubMed ID: 26448673
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Meropenem and Vaborbactam Room Temperature and Refrigerated Stability in Polyvinyl Chloride Bags and Elastomeric Devices.
Chen IH; Martin EK; Nicolau DP; Kuti JL
Clin Ther; 2020 Apr; 42(4):606-613. PubMed ID: 32139176
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements.
Jamieson C; Ozolina L; Seaton RA; Gilchrist M; Hills T; Drummond F; Wilkinson AS;
Eur J Hosp Pharm; 2022 Jul; 29(4):212-216. PubMed ID: 32978220
[TBL] [Abstract][Full Text] [Related]
10. Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy.
Jamieson C; Drummond F; Hills T; Ozolina L; Gilchrist M; Seaton RA; Santillo M; Wilkinson AS; Allwood MC
JAC Antimicrob Resist; 2021 Sep; 3(3):dlab141. PubMed ID: 34676364
[TBL] [Abstract][Full Text] [Related]
11. Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions.
Harmanjeet H; Jani H; Zaidi STR; Wanandy T; Castelino RL; Sud K; Peterson GM; Patel RP
Perit Dial Int; 2020 Sep; 40(5):470-476. PubMed ID: 32052692
[TBL] [Abstract][Full Text] [Related]
12. Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags.
Nalenz H; Köpf E; Dietel E
Int J Pharm Compd; 2018; 22(5):417-423. PubMed ID: 30384340
[TBL] [Abstract][Full Text] [Related]
13. Outpatient Parenteral Antimicrobial Therapy With Ceftolozane/Tazobactam via Continuous Infusion for Multidrug-Resistant
Álvarez Otero J; Lamas Ferreiro JL; Sanjurjo Rivo A; de la Fuente Aguado J
Open Forum Infect Dis; 2020 Nov; 7(11):ofaa409. PubMed ID: 33204747
[TBL] [Abstract][Full Text] [Related]
14. Shelf lives of aseptically prepared medicines--stability of piperacillin/tazobactam in PVC and non-PVC bags.
Rigge DC; Jones MF
J Pharm Biomed Anal; 2005 Sep; 39(1-2):339-43. PubMed ID: 16085149
[TBL] [Abstract][Full Text] [Related]
15. Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy.
Fernández-Rubio B; Herrera-Hidalgo L; de Alarcón A; Luque-Márquez R; López-Cortés LE; Luque S; Gutiérrez-Urbón JM; Fernández-Polo A; Gutiérrez-Valencia A; Gil-Navarro MV
Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140046
[TBL] [Abstract][Full Text] [Related]
16. Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration.
Thabit AK; Hamada Y; Nicolau DP
Am J Health Syst Pharm; 2017 Jan; 74(1):e47-e54. PubMed ID: 28007721
[TBL] [Abstract][Full Text] [Related]
17. In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers.
Bhattacharya S; Parekh S; Dedhiya M
Int J Pharm Compd; 2015; 19(5):432-6. PubMed ID: 26775451
[TBL] [Abstract][Full Text] [Related]
18. Stability of colistimethate sodium in a disposable elastomeric infusion device.
Abdulla A; van Leeuwen RW; de Vries Schultink AH; Koch BC
Int J Pharm; 2015; 486(1-2):367-9. PubMed ID: 25863116
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of Ceftolozane plus Tazobactam Studied in an In Vitro Pharmacokinetic Model of Infection.
MacGowan AP; Noel AR; Tomaselli SG; Nicholls D; Bowker KE
Antimicrob Agents Chemother; 2016 Jan; 60(1):515-21. PubMed ID: 26552975
[TBL] [Abstract][Full Text] [Related]
20. Determination of alternative ceftolozane/tazobactam dosing regimens for patients with infections due to Pseudomonas aeruginosa with MIC values between 4 and 32 mg/L.
Natesan S; Pai MP; Lodise TP
J Antimicrob Chemother; 2017 Oct; 72(10):2813-2816. PubMed ID: 29091209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
